Scientists have discovered that gut-born bacteria may hold the secret for treatments of everything from IBD to Parkinson’s ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...
Clinical Trials Arena on MSN
Kenai doses first patient in Phase I trial of cell therapy for Parkinson’s
Kenai Therapeutics has dosed the first patient in its multi-centre Phase I REPLACE trial evaluating the allogeneic neuron ...
Parkinson's disease (PD) is an age-related, progressive, neurodegenerative condition, caused by loss of dopamine-producing ...
The event brings together leading experts, patients and care partners for a day of education on navigating the disease.
People with restless leg syndrome may also have a higher risk for Parkinson's disease, a study from the Republic of Korea has ...
Van Andel Institute and Cure Parkinson's have renewed a funding agreement to support the International Linked Clinical Trials ...
Lindberg had Parkinson’s disease, the neurologist said, with all the classic symptoms. PD—as the scientists she would meet ...
Researchers are developing a greater understanding of Parkinson’s disease, the fastest growing neurodegenerative disease ...
An international study has found that wearable technology could help detect Parkinson's disease (PD) up to nine years before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results